RNSH teams identifying COVID-19 impact on heart health
RNSH Head of Cardiology and Kolling researcher Professor Ravinay Bhindi
The largest study of its type in Australia will investigate the impact of COVID-19 on younger patients, with new trends emerging around the cardiac complications from the Delta strain of the virus.
Launched last year, the AUS-COVID trial initially assessed more than 640 patients in 21 hospitals across Australia, recording cardiovascular complications. From this group, 125 were people were admitted to intensive care units and 92 patients died. Initial study results indicate one in 25 patients admitted to hospital with COVID-19 developed atrial fibrillation or abnormal heart rhythm, and this occurred more frequently in those aged over 65, in one in 16 patients. Abnormal heart rhythm can lead to stroke and requires prompt treatment. RNSH Head of Cardiology and Kolling researcher Professor Ravinay Bhindi said the trial found that other concerning complications of COVID-19 such as heart failure
and heart inflammation were not as common as expected, with one in 50 patients experiencing heart failure, and one person in 100 suffering clinically significant heart inflammation. “The initial results of the AUS-COVID study demonstrate that cardiac complications from COVID-19, while concerning, are not as common as we initially feared they would be,” he said. “The rates of complications were reassuringly lower than those published in other countries across Europe and North America.” As the Delta strain of COVID-19 continues to spread in parts of Australia, researchers will now shift their focus towards assessing the cardiac complications of this highly-contagious strain.
“We are seeing initial reports of an increase in cardiac complications, including a rise in the number of younger patients experiencing significant cardiac events, such as myocarditis, or inflammation of the heart,” Ravinay said. “These preliminary indications point to a concerning new trend for a group which has until now, largely escaped significant health complications from COVID-19.” Ravinay said the rising number of cases demonstrates the importance of the study to help inform clinicians about the likely outcomes and best models of care for these patients. “As the largest registry of cardiac complications from COVID-19 in Australia, it will have a key role in improving health outcomes, and potentially saving lives.”
32
NSLHDNEWS | 2021 YEAR IN REVIEW
Made with FlippingBook - professional solution for displaying marketing and sales documents online